Nature Cell acquired a stem cell manufacturing facility and is seeking BLA filing for its stem cell therapy.
1 report, 1 independent
Updated May 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Nature Cell acquired a stem cell manufacturing facility and is seeking BLA filing for its stem cell therapy.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- A network focused on cell and gene therapies is expanding to include sites in Northern California, involving the CA Institute for Regenerative Medicine and the FDA.
- Fate Therapeutics, based in San Diego, is seeking support for an accelerated regulatory pathway from the FDA.
- Mesoblast is seeking FDA review of the BLA for its product rexlemestrocel-L.
- FDA approval enables commercial opportunity involving CBRE Group.